ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Scope & Guideline

Pioneering Insights in Experimental Therapies

Introduction

Explore the comprehensive scope of ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0004-069x
PublisherDE GRUYTER POLAND SP Z O O
Support Open AccessNo
CountrySwitzerland
TypeJournal
Convergefrom 1954 to 1957, from 1959 to 1977, from 1979 to 2024
AbbreviationARCH IMMUNOL THER EX / Arch. Immunol. Ther. Exp.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND

Aims and Scopes

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS focuses on the intersection of immunology and experimental therapies, highlighting innovative research that advances our understanding of immune responses and therapeutic interventions.
  1. Immunological Mechanisms:
    The journal extensively covers the mechanisms of immune responses, including topics like T cell function, cytokine signaling, and the role of various immune cells in disease processes.
  2. Therapeutic Innovations:
    A key focus is on experimental therapies and innovations in immunotherapy, particularly regarding conditions like cancer, autoimmune diseases, and infectious diseases.
  3. Translational Research:
    The journal emphasizes studies that bridge laboratory findings with clinical applications, aiming to translate basic immunological research into therapeutic strategies.
  4. Pathogen-Host Interactions:
    Research exploring the dynamics between pathogens and host immune responses, including studies on viral infections and autoimmune responses.
  5. Regulatory and Tolerogenic Mechanisms:
    The journal addresses how immune tolerance and regulation can impact disease progression and therapy, especially in transplantation and autoimmune disorders.
  6. Emerging Technologies in Immunology:
    The incorporation of new technologies such as genomics, proteomics, and artificial intelligence in understanding immune responses and developing therapies.
Recent publications indicate a shift towards several emerging themes within the journal, reflecting current trends in immunology and therapeutic research.
  1. Cancer Immunotherapy:
    An increasing number of studies focus on immunotherapeutic approaches in oncology, highlighting CAR-T cell therapy and other innovative strategies to enhance anti-tumor immunity.
  2. Impact of Microbiome on Immunity:
    Research exploring the role of gut microbiota in modulating immune responses and its implications for various diseases is gaining traction, indicating a broader interest in microbiome-immune interactions.
  3. Artificial Intelligence in Immunology:
    There is a growing interest in the application of artificial intelligence and big data analytics to understand immune responses and improve therapeutic strategies.
  4. Vaccine Responses and Immunogenicity:
    With the emergence of new pathogens, studies assessing vaccine efficacy and immune responses, especially in the context of COVID-19, are increasingly prevalent.
  5. Personalized Medicine in Immunotherapy:
    The trend towards personalized approaches in immunotherapy, including tailored treatments based on individual genetic and immunological profiles, is becoming more prominent.

Declining or Waning

While some areas of research remain prominent, others have shown a decline in focus, suggesting shifting priorities in the journal's scope.
  1. Traditional Autoimmune Disease Models:
    Research using conventional autoimmune disease models appears to be waning, possibly due to a shift towards more complex and translational models that better mimic human diseases.
  2. Single Disease Focus:
    There is a noticeable decline in studies focusing solely on individual diseases, with more research now emphasizing holistic and systems biology approaches.
  3. Basic Immunology without Clinical Relevance:
    Studies that explore basic immunological principles without clear clinical implications are becoming less frequent, reflecting a trend towards research with direct therapeutic applications.

Similar Journals

IMMUNOBIOLOGY

Illuminating the path to breakthroughs in immunological science.
Publisher: ELSEVIER GMBHISSN: 0171-2985Frequency: 12 issues/year

IMMUNOBIOLOGY is a prestigious academic journal published by Elsevier GmbH that significantly contributes to the fields of hematology and immunology. With its ISSN 0171-2985 and E-ISSN 1878-3279, this journal has been disseminating impactful research since 1979, positioning itself at the forefront of immunological and hematological advances. The journal holds a commendable ranking of Q2 in Hematology and Q3 in both Immunology and Immunology and Allergy, indicating its relevance and influence within the scientific community, as reflected by its Scopus rankings. Although IMMUNOBIOLOGY operates under a subscription model, it remains dedicated to expanding knowledge across disciplines, fostering innovative research, and facilitating connections among researchers, professionals, and students. Situated in Munich, Germany, this journal is continually evolving and aims to remain an essential resource for the latest discoveries and insights in the realms of immunity and blood disorders, ultimately enhancing our understanding of complex biological systems.

SEMINARS IN IMMUNOLOGY

Leading the Charge in Immunological Research
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 1044-5323Frequency: 6 issues/year

SEMINARS IN IMMUNOLOGY, published by Academic Press Ltd - Elsevier Science Ltd, stands as a leading journal in the field of immunology and allergy, with an impressive impact factor that reflects its significant contribution to advancing research and discourse within these vital areas of medical science. Established in 1989, this esteemed journal has garnered a reputation for disseminating high-quality, peer-reviewed articles that span a broad spectrum of immunological topics, making it an essential resource for researchers, healthcare professionals, and students alike. Currently ranked Q1 in both Immunology and Allergy categories, SEMINARS IN IMMUNOLOGY ranks 39th among 233 journals in Immunology and Allergy and 43rd among 236 in Immunology and Microbiology according to Scopus, placing it in the 83rd and 81st percentiles respectively. This underscores its pivotal role in shaping the future of immunological research and clinical practices. While the journal operates under a subscription model with no open access option, it remains committed to providing comprehensive insights and fostering scholarly collaboration within the global immunology community.

INTERNATIONAL IMMUNOLOGY

Leading the Charge in Immunological Discoveries and Developments.
Publisher: OXFORD UNIV PRESSISSN: 0953-8178Frequency: 12 issues/year

INTERNATIONAL IMMUNOLOGY, published by OXFORD UNIV PRESS, stands out as a premier journal in the field of immunology, providing a vital platform for disseminating groundbreaking research and innovative developments within the discipline. With an impressive Q1 ranking in Immunology and Allergy, as well as in Medicine (miscellaneous), it consistently showcases high-impact studies that contribute to the advancement of immunological knowledge. The journal spans over three decades, from its inception in 1989 to its ongoing contributions as of 2024, thus solidifying its reputation in the scientific community. Researchers, professionals, and students will find valuable articles that delve into the complexities of immune responses, therapeutic interventions, and emerging immunological paradigms, ensuring INTERNATIONAL IMMUNOLOGY remains at the forefront of knowledge in the life sciences.

JOURNAL OF EXPERIMENTAL MEDICINE

Pioneering Discoveries in Experimental Medicine
Publisher: ROCKEFELLER UNIV PRESSISSN: 0022-1007Frequency: 12 issues/year

JOURNAL OF EXPERIMENTAL MEDICINE, published by Rockefeller University Press, is a renowned peer-reviewed journal dedicated to advancing the field of experimental medicine since its inception in 1896. With an impressive impact factor and categorized in the Q1 quartile for Immunology, Immunology and Allergy, and Miscellaneous Medicine, this journal stands at the forefront of medical research and innovation. It provides a prestigious platform for scholars and practitioners to disseminate groundbreaking findings that drive the understanding of disease mechanisms and therapeutic strategies. While the journal is not open access, it maintains high visibility and engagement within the scientific community, fostering collaboration among researchers, professionals, and students alike. The journal's consistent ranking in the top percentiles of Scopus illustrates its significant impact and commitment to excellence in medical research.

NATURE IMMUNOLOGY

Connecting researchers to the forefront of immune system studies.
Publisher: NATURE PORTFOLIOISSN: 1529-2908Frequency: 12 issues/year

NATURE IMMUNOLOGY is a premier academic journal published by NATURE PORTFOLIO, dedicated to advancing the field of immunology. With an impressive impact factor that reflects its esteemed position, this journal ranks in the top quartile (Q1) of renowned categories, including Immunology and Allergy. Serving as a crucial platform for researchers, professionals, and students, NATURE IMMUNOLOGY showcases cutting-edge research, comprehensive reviews, and insightful perspectives that drive innovation in immunological science. Based in the United Kingdom, this journal has been a vital contributor to the global discourse on immune responses and related diseases since its inception in 2000. Researchers can benefit from its rigorous peer-review process, ensuring that only high-quality studies are disseminated, thus enhancing their academic pursuits and practical applications. Explore the latest findings and trends within this flourishing discipline, making NATURE IMMUNOLOGY an essential resource for anyone engaged in the study of the immune system.

CELLULAR IMMUNOLOGY

Fostering Innovation in Immunological Science
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0008-8749Frequency: 12 issues/year

CELLULAR IMMUNOLOGY is a prestigious journal published by Academic Press Inc. Elsevier Science, dedicated to advancing the field of immunology. Established in 1970 and converging ongoing research up to 2024, this journal has carved out a significant niche within the academic community, boasting a notable Q2 ranking in the Immunology category and holding a respectable 67th percentile ranking within Scopus for its contributions to the disciplines of Immunology and Microbiology. The journal serves as a vital platform for disseminating high-quality research, reviews, and methodologies that elucidate the intricacies of cellular immune responses, thereby benefiting researchers, professionals, and students alike. Although it does not offer open access, the journal's impact is evidenced by its comprehensive coverage of pioneering studies and ongoing developments in the immunological sciences, positioning it as an essential resource for those seeking to deepen their understanding and engage with the latest findings in cellular immunology.

Central European Journal of Immunology

Pioneering Discoveries in Allergy and Immunology
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1426-3912Frequency: 4 issues/year

Central European Journal of Immunology is a premier publication dedicated to advancing the field of immunology and allergy research. Established in 1996 and published by TERMEDIA PUBLISHING HOUSE LTD, this open access journal has consistently provided a platform for innovative research and comprehensive reviews since its transition to open access in 2002. With an ISSN of 1426-3912 and E-ISSN of 1644-4124, it embraces a global readership while being rooted in Poland. The journal, with a notable Q3 ranking in both the categories of immunology and allergy in 2023, positions itself within the competitive landscape of scientific discourse, as reflected in its Scopus rankings. Designed for researchers, professionals, and students, the Central European Journal of Immunology not only disseminates significant findings but also fosters collaboration and innovation in the immunological sciences, making it a vital resource for those seeking to stay current in this rapidly evolving field.

Innate Immunity

Connecting Science and Health through Immunology
Publisher: SAGE PUBLICATIONS LTDISSN: 1753-4259Frequency: 6 issues/year

Innate Immunity, published by SAGE Publications Ltd, serves as a vital platform for disseminating cutting-edge research in the fields of immunology, microbiology, cell biology, and infectious diseases. With an ISSN of 1753-4259 and an E-ISSN of 1753-4267, this journal has been a prominent contributor to the academic community since its inception in 1996, focusing on the innate immune response and its implications for health and disease. Holding a respectable impact factor and categorized in the Q2 and Q3 quartiles across various relevant domains, Innate Immunity ranks competitively in major databases, including Scopus, where it appears in the top 75th percentile for Infectious Diseases. Researchers and professionals are encouraged to explore its wealth of articles that are pivotal in bridging fundamental immunology with clinical applications, fostering a deeper understanding of immune mechanisms vital for combating human diseases.

IMMUNOLOGY LETTERS

Pioneering Research in Immunity and Allergy
Publisher: ELSEVIERISSN: 0165-2478Frequency: 12 issues/year

IMMUOLOGY LETTERS, published by Elsevier, is a distinguished journal in the field of immunology, focusing on the latest advancements and findings that significantly influence immunological research and clinical applications. Established in 1979, the journal has evolved to cater to a global readership, featuring high-quality peer-reviewed articles across a diverse spectrum of topics related to immunity and allergic responses. With an impressive Q2 category ranking in both Immunology and Allergy as of 2023, it holds a strong position within the scientific community, evidenced by its commendable Scopus rankings (Rank #71/233 in Medicine - Immunology and Allergy and Rank #85/236 in Immunology and Microbiology - Immunology). While primarily subscription-based, the journal aims to foster knowledge dissemination that encourages collaboration among researchers and practitioners alike, making significant contributions to the understanding of immune mechanisms. The journal is integral for educators, students, and professionals aiming to stay abreast of current trends and breakthroughs in the immune system's intricate functions.

CURRENT OPINION IN IMMUNOLOGY

Connecting Scholars in the World of Immunology
Publisher: CURRENT BIOLOGY LTDISSN: 0952-7915Frequency: 6 issues/year

CURRENT OPINION IN IMMUNOLOGY is a prestigious journal dedicated to the dynamic field of immunology, published by CURRENT BIOLOGY LTD in the United Kingdom. With an ISSN of 0952-7915 and an E-ISSN of 1879-0372, this journal has been a cornerstone of scholarly communication since its inception in 1988 and continues to disseminate cutting-edge research and reviews aimed at advancing our understanding of immune responses. Holding a remarkable Q1 ranking in both Immunology and Allergy categories for 2023, it ranks impressively within the top percentiles in its field, securing 27th233 in Immunology and Allergy and 31st out of 236 in Immunology and Microbiology. Emphasizing high-impact research, the journal provides researchers, professionals, and students with valuable insights into emerging trends and critical developments. As a vital resource in immunological research, it serves as a platform for disseminating innovative findings, fostering collaboration, and enhancing scholarly exchange in a rapidly evolving scientific landscape.